| |
|
|
 | Acesso ao texto completo restrito à biblioteca da Embrapa Caprinos e Ovinos. Para informações adicionais entre em contato com cnpc.biblioteca@embrapa.br. |
|
Registro Completo |
|
Biblioteca(s): |
Embrapa Caprinos e Ovinos. |
|
Data corrente: |
30/03/2000 |
|
Data da última atualização: |
02/10/2023 |
|
Autoria: |
HODGON, A. L. M.; CARTER, K.; TACHEDJAN, M.; KRYWULT, J.; CORNER, L. A.; McCOLL, M.; CAMERON, A. |
|
Título: |
Efficacy of an ovine Caseous lymphadenitis vaccine formulated using a genetically inactive form of the Corynebacterium pseudotuberculosis phospholipase D. |
|
Ano de publicação: |
1999 |
|
Fonte/Imprenta: |
Vaccine, v. 17, n. 7/8, p. 802-808, Feb. 1999. |
|
DOI: |
10.1016/s0264-410x(98)00264-3. |
|
Idioma: |
Inglês |
|
Conteúdo: |
Abstract: Caseous lymphadenitis (CLA) is an economically significant disease of sheep caused by the gram-positive bacterium Corynebacterium pseudotuberculosis. CLA vaccines are currently formulated using formalin inactivated culture supernatants that are rich in the C. pseudotuberculosis phospholipase D (PLD) exotoxin. One alternative to chemical detoxification is to inactivate the PLD genetically. This procedure not only provides a means to remove an onerous chemical treatment step but also the opportunity to increase gene expression, therefore improve protein yields. Using site-specific mutagenesis the C. pseudotuberculosis PLD was inactivated by substituting a serine residue at histidine 20 within the enzyme active site. CLA vaccine formulated using genetically inactivated PLD protected 44% of sheep against C. pseudotuberculosis challenge compared with 95% protection offered by the formalin inactivated preparation. Since there was no apparent difference in immune response mounted by vaccinated sheep the reason for this variation in vaccine efficacy remains unclear. Although genetic inactivation can be a convenient means to produce toxoid vaccines its use to develop a new CLA vaccine provided no net benefit over the conventional formulation. |
|
Thesagro: |
Corynebacterium Pseudotuberculosis; Linfadenite Caseosa. |
|
Thesaurus Nal: |
Bacterial vaccines; Caseous lymphadenitis; Formaldehyde; Immunology; Inactivated vaccines; Phospholipase D; Sheep diseases; Synthetic vaccines. |
|
Categoria do assunto: |
H Saúde e Patologia |
|
Marc: |
LEADER 02286naa a2200325 a 4500
001 1524105
005 2023-10-02
008 1999 bl uuuu u00u1 u #d
024 7 $a10.1016/s0264-410x(98)00264-3.$2DOI
100 1 $aHODGON, A. L. M.
245 $aEfficacy of an ovine Caseous lymphadenitis vaccine formulated using a genetically inactive form of the Corynebacterium pseudotuberculosis phospholipase D.$h[electronic resource]
260 $c1999
520 $aAbstract: Caseous lymphadenitis (CLA) is an economically significant disease of sheep caused by the gram-positive bacterium Corynebacterium pseudotuberculosis. CLA vaccines are currently formulated using formalin inactivated culture supernatants that are rich in the C. pseudotuberculosis phospholipase D (PLD) exotoxin. One alternative to chemical detoxification is to inactivate the PLD genetically. This procedure not only provides a means to remove an onerous chemical treatment step but also the opportunity to increase gene expression, therefore improve protein yields. Using site-specific mutagenesis the C. pseudotuberculosis PLD was inactivated by substituting a serine residue at histidine 20 within the enzyme active site. CLA vaccine formulated using genetically inactivated PLD protected 44% of sheep against C. pseudotuberculosis challenge compared with 95% protection offered by the formalin inactivated preparation. Since there was no apparent difference in immune response mounted by vaccinated sheep the reason for this variation in vaccine efficacy remains unclear. Although genetic inactivation can be a convenient means to produce toxoid vaccines its use to develop a new CLA vaccine provided no net benefit over the conventional formulation.
650 $aBacterial vaccines
650 $aCaseous lymphadenitis
650 $aFormaldehyde
650 $aImmunology
650 $aInactivated vaccines
650 $aPhospholipase D
650 $aSheep diseases
650 $aSynthetic vaccines
650 $aCorynebacterium Pseudotuberculosis
650 $aLinfadenite Caseosa
700 1 $aCARTER, K.
700 1 $aTACHEDJAN, M.
700 1 $aKRYWULT, J.
700 1 $aCORNER, L. A.
700 1 $aMcCOLL, M.
700 1 $aCAMERON, A.
773 $tVaccine$gv. 17, n. 7/8, p. 802-808, Feb. 1999.
Download
Esconder MarcMostrar Marc Completo |
|
Registro original: |
Embrapa Caprinos e Ovinos (CNPC) |
|
|
Biblioteca |
ID |
Origem |
Tipo/Formato |
Classificação |
Cutter |
Registro |
Volume |
Status |
URL |
Voltar
|
|
|
| Registros recuperados : 1 | |
| 1. |  | SOUZA, P. V. D. de; BERJON, M. A.; ALMELA ORENGA, V.; AGUSTÍ FROFRIA, M. Desenvolvimento do citrange 'Troyer' infectado com fungo micorrízico, em dois substratos de cultivo. Pesquisa Agropecuária Brasileira, Brasília, DF, v. 32, n. 10, p. 1039-1045, out. 1997. Título em inglês: Troyer citrange growth inoculated with mycorrhizal fungus, in two growing media.| Biblioteca(s): Embrapa Unidades Centrais. |
|    |
| Registros recuperados : 1 | |
|
| Expressão de busca inválida. Verifique!!! |
|
|
